NMPA Approval

Tazemetostat Hydrobromide Tablets

Approval Number

国药准字HJ20250031

Registration Date

March 18, 2025

Drug Information

Generic Name

氢溴酸他泽司他片

Trade Name

达唯珂

Dosage Form

片剂

Strength

200mg（按C₃₄H₄₄N₄O₄计）

Drug Type

化学药品

Registration Date

March 18, 2025

Expiry Date

March 17, 2030

Company Address

One Main St, 7th Floor, Cambridge, MA 02142 United States of America

Company Address

2110 E Galbraith Road, Cincinnati, OH 45237 United States of America

Empowering clinical research with data-driven insights and AI-powered tools.

氢溴酸他泽司他片 - NMPA 批准文号 | MedPath